Neuroscientific Biopharmaceuticals Ltd (NSB) — Capital Reinvestment Ratio

Latest as of June 2024: 0.00x

Neuroscientific Biopharmaceuticals Ltd (NSB) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow (AU$1.62 Million) in capital expenditures (AU$1.82K). Check NSB tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

AU$1.62 Million

AUD

Capital Expenditures

AU$1.82K

AUD

Data as of

Jun 2024

Most recent filing

Neuroscientific Biopharmaceuticals Ltd Capital Reinvestment Ratio (2024–2024)

This chart tracks Neuroscientific Biopharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Neuroscientific Biopharmaceuticals Ltd cash conversion from operations.

Annual Capital Reinvestment Ratio for Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Year-by-year Capital Reinvestment Ratio for Neuroscientific Biopharmaceuticals Ltd from 2024 to 2024. See NSB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2024	0.04x	AU$44.25K	AU$1.81K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow